# Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices in line with those paid in other developed nations.

*biotech · news · 2026-04-02 · Reuters*

## Key points

- Sixteen major pharmaceutical firms agreed to match U.S. drug prices to those in developed countries.
- The TrumpRx.gov platform will enable direct-to-consumer sales of discounted drugs from participating companies.
- Novo Nordisk will reduce Ozempic and Wegovy prices to $350 monthly through TrumpRx, down from $1,000-$1,350.
- Bristol Myers Squibb will provide Eliquis to Medicaid for free and donate seven tons of its active ingredient.
- Regeneron is the only large pharmaceutical company yet to sign an agreement, though negotiations continue.

**Companies:** Pfizer, Johnson & Johnson, AstraZeneca, Novartis, Eli Lilly, AbbVie, Bristol Myers Squibb, Gilead Sciences, Merck, Amgen, Novo Nordisk, Sanofi, GSK, Boehringer Ingelheim
**Countries:** United States, Germany

[Read the full story on Reuters](https://www.reuters.com/business/healthcare-pharmaceuticals/global-pharma-companies-that-have-publicly-announced-trump-drug-pricing-2026-04-02/)

---

Canonical: https://newsio.io/n/135701f7-a68a-41e1-9575-e14777c0321a/trump-secured-agreements-with-16-major-pharmaceutical-companies-to-bring-u-s-pre
Summarized by Newsio from Reuters. https://newsio.io/how-it-works